White label – Pompe disease - ClinicalTrials.eu

Study Comparing Sacituzumab Govitecan with Other Treatments for Patients with HR+/HER2- Metastatic Breast Cancer After Endocrine Therapy

Not recruiting

3 1 1 1
Investigated Diseases:
- Hormone receptor negative HER2 positive breast cancer
- Hormone receptor positive breast cancer
Investigated Drugs:
+5
Study Comparing Setrusumab and Bisphosphonates for Children with Osteogenesis Imperfecta

Not recruiting

3 1 1 1
Investigated Diseases:
- Osteogenesis imperfecta
Investigated Drugs:
Study on Long-Term Safety of Ligelizumab for Patients with Food Allergies

Not recruiting

3 1 1
Investigated Diseases:
- Food allergy
Investigated Drugs:
Study Comparing Gadoquatrane with Gadoteric Acid, Gadoteridol, and Gadobutrol for MRI in Patients with Non-CNS Conditions

Not recruiting

3 1 1 1
Investigated Diseases:
- Magnetic resonance imaging
- Neuropathy peripheral
Investigated Drugs:
+2
Study of Tislelizumab, LBL-007, and BGB-15025 in Patients with Advanced Non-Small Cell Lung Cancer

Not recruiting

2 1 1 1
Investigated Diseases:
- Non-small cell lung cancer metastatic
Investigated Drugs:
Study on the Effectiveness and Safety of Aflibercept for Patients with Vision Loss Due to Macular Edema from Retinal Vein Blockage

Not recruiting

3 1 1 1
Investigated Diseases:
- Macular oedema
- Retinal vein occlusion
Investigated Drugs:
- Fluorescein Sodium
- Aflibercept
+8
Study of MK-7684A, Etoposide, and Platinum Drugs for Patients with Extensive-Stage Small Cell Lung Cancer

Not recruiting

3 1 1
Investigated Drugs:
+8
Study on the Effects of Retatrutide for Patients with Severe Obesity and Cardiovascular Disease

Not recruiting

3 1
Investigated Diseases:
- Cardiovascular disorder
- Obesity
Investigated Drugs:
- Ly3437943 Sodium
Study Comparing Tisagenlecleucel with Standard Treatment for Adults with Relapsed or Refractory Follicular Lymphoma

Not recruiting

3 1 1 1
Investigated Drugs:
+1
Study on the Safety and Effectiveness of Deucravacitinib for Patients with Active Discoid and/or Subacute Cutaneous Lupus Erythematosus

Not recruiting

2 1
Investigated Diseases:
Investigated Drugs:
- Deucravacitinib

Full Name *

e-Mail *

Country Prefix *

Phone Number *

Nationality *

Gender *

Check all consents

Check all consents

I accept the Terms and Conditions and Privacy Policy *

*I accept the Terms and Conditions and Privacy Policy

I consent to receiving commercial information from the Service Operator *

*I consent to receiving commercial information from the Service Operator

I consent to the use of telecommunications terminal equipment and automated calling systems by the Service Operator for marketing communication purposes *

*I consent to the use of telecommunications terminal equipment and automated calling systems by the Service Operator for marketing communication purposes

We use cookies